Trial Profile
Safety and IOP Lowering Efficacy of Low Dose Travoprost Ophthalmic Solutions Dosed BID Compared to TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2014
Price :
$35
*
At a glance
- Drugs Travoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 12 Sep 2014 New trial record